All Pfizer published press releases by date and/or category of news
10.12.2022 Vaccines COVID-19 Vaccines Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine Booster in Children 5 Through 11 Years of Age 10.05.2022 Financial Investments Pfizer Completes Acquisition of Global Blood Therapeutics 10.04.2022 Research and Pipeline Research Pfizer Announces Positive Topline Results from Phase 3 TALAPRO-2 Trial
Pfizer Media Relations
We encourage everyone to view our press releases, press statements, and press kits to stay up to date on Pfizer news.
However, to ensure that customers, investors, and others receive the appropriate attention, Pfizer media contacts may only respond to calls and emails from professional journalists.
United States, Canada and Latin America
What we need
To best help us help you, please be prepared to provide your name and email address, a summary of the article you're working on and your deadline.
Stay up to date on the latest news and alerts through the Pfizer Wire
Sign up to receive real-time updates on Pfizer’s news from the Pfizer Media Relations team delivered directly to your inbox.